<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mazzaglia</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Straus</surname>
    <given-names>SMJ</given-names>
   </name>
   <name>
    <surname>Arlett</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>da Silva</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Janssen</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Raine</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Study design and evaluation of risk minimization measures: a review of studies submitted to the European Medicines Agency for cardiovascular, endocrinology, and metabolic drugs</article-title>
  <source>Drug Saf</source>
  <year>2017</year>
  <volume>41</volume>
  <fpage>1</fpage>
  <lpage>12</lpage>
 </element-citation>
</ref>
